Found 6 results
Filters: Author is M.R. Melo  [Clear All Filters]
R. B. Castro, Longui, C. A., Faria, C. D. C., Silva, T. S., Richeti, F., Rocha, M. N., Melo, M. R., Pereira, W. L., Chamlian, E. G., and Rivetti, L. A., Tissue-specific adaptive levels of glucocorticoid receptor alpha mRNA and their relationship with insulin resistance, vol. 11, pp. 3975-3987, 2012.
Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, et al. (2009). Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94: 2692-2701. PMid:19470627   Balachandran A, Guan H, Sellan M, van US, et al. (2008). Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology 149: 4069-4079. PMid:18467433 PMCid:2488250   Bansilal S, Farkouh ME and Fuster V (2007). Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am. J. Cardiol. 99: 6B-14B. PMid:17307054   Benetos A, Thomas F, Pannier B, Bean K, et al. (2008). All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am. J. Cardiol. 102: 188-191. PMid:18602519   Deveci E, Yesil M, Akinci B, Yesil S, et al. (2009). Evaluation of insulin resistance in normoglycemic patients with coronary artery disease. Clin. Cardiol. 32: 32-36. PMid:19143010   Di Blasio AM, van Rossum EF, Maestrini S, Berselli ME, et al. (2003). The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin. Endocrinol. 59: 68-74.   Duma D, Jewell CM and Cidlowski JA (2006). Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 102: 11-21. PMid:17070034   Escher G, Galli I, Vishwanath BS, Frey BM, et al. (1997). Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J. Exp. Med. 186: 189-198. PMid:9221748 PMCid:2198986   Faria CD, Castro RB, Longui CA, Kochi C, et al. (2010). Impact of prolonged low-grade physical training on the in vivo glucocorticoid sensitivity and on glucocorticoid receptor-alpha mRNA levels of obese adolescents. Horm. Res. Paediatr. 73: 458-464. PMid:20407233   Fernandes-Rosa FL, Bueno AC, de Souza RM, de CM, et al. (2010). Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels. J. Endocrinol. Invest. 33: 472-477. PMid:19955850   Gathercole LL, Bujalska IJ, Stewart PM and Tomlinson JW (2007). Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue. J. Clin. Endocrinol. Metab. 92: 4332-4339. PMid:17711920   Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, et al. (2006). The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res. Clin. Pract. 72: 219-220. PMid:16310881   Georgakopoulos A and Tsawdaroglou N (1996). Insulin potentiates the transactivation potency of the glucocorticoid receptor. FEBS Lett. 381: 177-182.   Gesina E, Blondeau B, Milet A, Le N, I, et al. (2006). Glucocorticoid signalling affects pancreatic development through both direct and indirect effects. Diabetologia 49: 2939-2947. PMid:17001468 PMCid:1885455   Goedecke JH, Wake DJ, Levitt NS, Lambert EV, et al. (2006). Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin. Endocrinol. 65: 81-87. PMid:16817824   Gross KL, Lu NZ and Cidlowski JA (2009). Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol. Cell Endocrinol. 300: 7-16. PMid:19000736 PMCid:2674248   Hoppmann J, Perwitz N, Meier B, Fasshauer M, et al. (2010). The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J. Endocrinol. 204: 153-164. PMid:19939912   Longui CA and Faria CD (2009). Evaluation of glucocorticoid sensitivity and its potential clinical applicability. Horm. Res. 71: 305-309. PMid:19506386   Löwenberg M, Tuynman J, Scheffer M, Verhaar A, et al. (2006). Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling. Endocrinology 147: 3555-3562. PMid:16574792   Lu NZ and Cidlowski JA (2005). Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 18: 331-342. PMid:15866175   Lundgren M, Buren J, Ruge T, Myrnas T, et al. (2004). Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J. Clin. Endocrinol. Metab. 89: 2989-2997. PMid:15181089   Masuzaki H, Paterson J, Shinyama H, Morton NM, et al. (2001). A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166-2170. PMid:11739957   Melo MR, Faria CD, Melo KC, Reboucas NA, et al. (2004). Real-time PCR quantitation of glucocorticoid receptor alpha isoform. BMC Mol. Biol. 5: 19. PMid:15507144 PMCid:529441   Mericq V, Medina P, Bouwman C, Johnson MC, et al. (2009). Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children. Horm. Res. 71: 89-93. PMid:19129713   Reaven GM (2008). Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol. Metab. Clin. North Am. 37: 581-viii. PMid:18775353   Rebuffé-Scrive M, Bronnegard M, Nilsson A, Eldh J, et al. (1990). Steroid hormone receptors in human adipose tissues. J. Clin. Endocrinol. Metab. 71: 1215-1219. PMid:2229280   Reynolds RM, Chapman KE, Seckl JR, Walker BR, et al. (2002). Skeletal muscle glucocorticoid receptor density and insulin resistance. JAMA 287: 2505-2506. PMid:12020330   Rosenbaum P and Ferreira SRG (2003). An update on cardiovascular risk of metabolic syndrome. Arq. Bras. Endocrinol. Metab. 47: 220-227.   Sousa Silva T, Longui CA, Rocha MN, Faria CD, et al. (2010). Prolonged physical training decreases mRNA levels of glucocorticoid receptor and inflammatory genes. Horm. Res. Paediatr. 74: 6-14. PMid:20407229   Stewart PM (2005). Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome - 11beta-hydroxysteroid dehydrogenase type 1. Clin. Med. 5: 142-146. PMid:15847006   Vegiopoulos A and Herzig S (2007). Glucocorticoids, metabolism and metabolic diseases. Mol. Cell Endocrinol. 275: 43-61. PMid:17624658   Wake DJ, Rask E, Livingstone DE, Soderberg S, et al. (2003). Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J. Clin. Endocrinol. Metab. 88: 3983-3988. PMid:12915696   Wallace AD and Cidlowski JA (2001). Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276: 42714-42721. PMid:11555652   Wallace TM, Levy JC and Matthews DR (2004). Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495. PMid:15161807   Wang M (2005). The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr. Metab. 2: 3. PMid:15689240 PMCid:548667   Wassink AM, Van Der Graaf Y, Olijhoek JK and Visseren FL (2008). Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Eur. Heart J. 29: 213-223. PMid:18199567   Webster JC, Jewell CM, Bodwell JE, Munck A, et al. (1997). Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 272: 9287-9293. PMid:9083064   Whorwood CB, Donovan SJ, Wood PJ and Phillips DI (2001). Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? J. Clin. Endocrinol. Metab. 86: 2296-2308. PMid:11344242   Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, et al. (2002). Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 51: 1066-1075. PMid:11916927   Zennaro MC, Caprio M and Feve B (2009). Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol. Metab. 20: 444-451. PMid:19800255
L. O. Cavalcante, Melo, M. R., Dinis, V. G., Castro, R. B., Souza, B. D. B., and Longui, C. A., Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients, vol. 9, pp. 2300-2310, 2010.
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002). Guidelines for the management of rheumatoid arthritis. Arthitis Rheum. 46: 328-346. PMid:11840435   Asahara H, Fujisawa K, Kobata T, Hasunuma T, et al. (1997). Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 40: 912-918. PMid:9153554   Baeuerle PA and Baltimore D (1996). NF-kappa B: ten years after. Cell 87: 13-20.   Baldwin AS Jr (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683. PMid:8717528   Bértolo MB, Brenol CV, Schainberg CG, Neubarth F, et al. (2007). Atualização do consenso brasileiro no diagnóstico e tratamento da artrite reumatóide. Rev. Bras. Reumatol. 47: 151-159.   Boss B and Neeck G (2000). Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis. Z. Rheumatol. (Suppl 2) 59: II-62-II-64.   Brenol CV, Monticielo OA, Xavier RM and Brenol JCT (2007). Artrite reumatóide e aterosclerose. Rev. Assoc. Med. Bras. 53: 465-470. PMid:17952359   Callahan LF, Pincus T, Huston JW III, Brooks RH, et al. (1997). Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res. 10: 381-394. PMid:9481230   Carlsson AM (1983). Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16: 87-101.   Cobra JF, Melo MR, Faria CD, Longui CA, et al. (2009). Simultaneous evaluation of in vivo glucocorticoid sensitivity and expression of glucocorticoid receptor alpha-isoform in rheumatoid arthritis patients. Arq. Bras. Endocrinol. Metabol. 53: 24-30. PMid:19347182   Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, et al. (1997). Circadian relationships between interleukin (IL)- 6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82: 1279-1283. PMid:9100607   De Bosscher K, Vanden Berghe W and Haegeman G (2001). Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 15: 219-227. PMid:11158329   Eggert M, Schulz M and Neeck G (2001). Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases. J. Steroid Biochem. Mol. Biol. 77: 185-191.   Eggert M, Kluter A, Rusch D, Schmidt KL, et al. (2002). Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis. J. Rheumatol. 29: 2500-2506. PMid:12465142   Faria CD, Cobra JF, Sousa E Silva, Melo MR, et al. (2008). A very low dose intravenous dexamethasone suppression test as an index of glucocorticoid sensitivity. Horm. Res. 69: 357-362. PMid:18504395   Faria CDC, Castro RB, Longui CA, Kochi C, et al. (2010). Impact of prolonged low-grade physical training on the in vivo glucocorticoid sensitivity and on glucocorticoid receptor mRNA levels of obese adolescents. Horm. Res. Paediatr. 73: 458-464. PMid:20407233   Firestein GS (2004). NF-kappaB: Holy Grail for rheumatoid arthritis? Arthritis Rheum. 50: 2381-2386. PMid:15334448   Fries JF, Spitz PW and Young DY (1982). The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J. Rheumatol. 9: 789-793. PMid:7175852   Fujisawa K, Aono H, Hasunuma T, Yamamoto K, et al. (1996). Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 39: 197-203. PMid:8849369   Ghosh S, May MJ and Kopp EB (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260. PMid:9597130   Longui CA and Faria CD (2009). Evaluation of glucocorticoid sensitivity and its potential clinical applicability. Horm. Res. 71: 305-309. PMid:19506386   Louzada-Junior P, Souza BDB, Toledo RA and Ciconelli RM (2007). Análise descritiva das características demográficas e clínicas de pacientes com artrite reumatóide no estado de São Paulo, Brasil. Rev. Bras. Reumatol. 47: 84-90.   McKay LI and Cidlowski JA (1999). Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20: 435-459. PMid:10453354